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Kupffer cells, tissue-resident macrophage lineage cell, are enriched in vertebrate liver. The mouse F4/80+ Kupffer cells have
been subclassified into two subpopulations according to their phenotype and function: CD68+ subpopulation with potent reactive
oxygen species (ROS) production and phagocytic capacities, and CD11b+ subpopulation with a potent capacity to produce T
helper 1 cytokines. In addition, CD11b+ Kupffer cells/macrophages may be migrated from the bone marrow or spleen, especially
in inflammatory conditions of the liver. For analyzing diverse Kupffer cell subsets, we infected mice with Listeria monocytogenes
and analyzed the phenotype variations of hepatic Kupffer cells. During L.monocytogenes infection, hepatic CD69+ Kupffer cells
were significantly induced and expanded, and CD69+ Kupffer cells expressed higher level of CD11b, and particularly high level
of membrane-bound TGF-β1 (mTGF-β1) but lower level of F4/80. We also found that clodronate liposome administration did
not eliminate hepatic CD69+ Kupffer cell subset. We consider the hepatic CD69+ Kupffer cell population corresponds to CD11b+
Kupffer cells, the bone marrow-derived population. Hepatic CD69+ Kupffer cells suppressed Ag-nonspecific and OVA-specific
CD4 T cell proliferation through mTGF-β1 both in vitro and in vivo, meanwhile, they did not interfere with activation of CD4 T
cells. Thus, we have identified a new subset of inflammation-induced CD69+ Kupffer cells which can feedback inhibit CD4 T cell
response via cell surface TGF-β1 at the late stage of immune response against infection. CD69+ Kupffer cells may contribute to
protect host from pathological injure by preventing overactivation of immune response.
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INTRODUCTION
Kupffer cells, an abundant population of macrophages that
reside in the sinusoids of the liver, play a critical role in
both liver homeostasis and immunoregualtion, performing
essential tissue-specific functions as well as protecting the
organism from infection (Crispe, 2009; Parker and Picut,
2005; Jenne and Kubes, 2013). Kupffer cells constitute the
first innate immune cell population of the body to deal with
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bacteria, bacterial endotoxins and microbial debris derived
from the gastrointestinal tract and transported to the liver
via the portal vein (Vollmar and Menger, 2009; Zhang et al.,
2009). Together with the sinusoidal endothelial cells, natural
killer T cells, dendritic cells and soluble compounds such as
complement factors and acute phase proteins, Kupffer cells,
an important component of innate immunity, make rapid
response to potentially dangerous factors. This is extremely
critical, since there are lots of pathogen-derived products
coming from venous portal blood, such as lipopolysaccha-
ride, and pathogens from the gut, which need to be eliminated
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from the circulation to avoid systemic immune activation.
The fact that Kupffer cells constitute 80%−90% of tissue
macrophages present in the body suggest a predominant role
of the liver in systemic as well as regional defense.
Besides their barrier (Vollmar and Menger, 2009) and jan-
itor function (Sitia et al., 2011; Bellone et al., 1997), Kupf-
fer cells have been demonstrated to play an important role in
the response to pathogens, including viruses. Until now, it
has been discovered several possible anti-viral roles of Kupf-
fer cells, including binding and/or uptake of virus inducing
immune recognition and the production of pro-inflammatory
factors resulting in inhibition of viral replication in hepato-
cytes, activation of neighboring cells, and attraction, activa-
tion, and interaction with other immune cells, which will fur-
ther increase the anti-viral and inflammatory response. These
immune activating roles of Kupffer cells are beneficial to
combat viruse infection in the early stage after infection, but
may also contribute to tissue damage and the development of
fibrosis and cirrhosis during chronic viral hepatitis (Zhao et
al., 2014). Furthermore, Kupffer cells also have immune reg-
ulatory functions, either through direct virus-Kupffer cells in-
teraction, or as a component of the complex tolerogenic liver
environment. These qualities may counteract the develop-
ment of effective anti-viral immunity and support viral persis-
tence during viruse-infection and promoting related disease
pathogenesis (Thimme et al., 2001; Day et al., 2002; Lauer et
al., 2002; Rehermann and Nascimbeni, 2005; Boonstra et al.,
2008; Jager et al., 2016).
The different phenotypes of Kupffer cells attribute to their
specialized function. Kupffer cells were identified in the early
1970s as peroxidase-positive cells with cytoplasm containing
numerous granules and vacuoles, and occasional tubular, ver-
miform invaginations (Fahimi, 1970; Klockars and Reitamo,
1975; Crofton et al., 1978; Widmann et al., 1972). At present,
human Kupffer cells are identified by immunohistochemistry
or flow cytometry using antibodies directed against CD68,
CD14, and CD16 (Tu et al., 2008; Brown et al., 2001; Baldus
et al., 1998). However, it is important to aware that these
markers are not unique for human Kupffer cells, but are also
expressed on monocytes, which are also documented as a
source of precursor cells for Kupffer cells, and/or dendritic
cells (Gregori et al., 2010). Rat Kupffer cells are commonly
identified by antibodies against CD68 or CD163 (ED1 and
ED2, respectively) (Dijkstra et al., 1985), and mouse Kupffer
cells by the F4/80 marker (Austyn and Gordon, 1981). How-
ever, also the rat and mouse markers are not characteristic for
Kupffer cells, but are shared with other myeloid cells.
The identification of Kupffer cells that exists under patho-
logical conditions is even more difficulty than under steady
state conditions. In pathological process, cellular infiltrates
are observed consisting of inflammatory monocytes and/or
dendritic cells that share certain surface markers with Kupf-
fer cells. In rat studies, large and small Kupffer cells were
proved to be present in a distinct area within the liver, i.e., in
the peri-portal, and peri-venous and mid-zonal area, respec-
tively, and two subpopulations of Kupffer cells have been
isolated from rat liver tissue: ED1+ED2− and ED1+ED2+
cells (Bouwens et al., 1986; Kono et al., 2002; Sleyster and
Knook, 1982; Dixon et al., 1986). Similarly, some studies
have suggested that there are two subpopulations of mouse
Kupffer cells: F4/80+CD68+ and F4/80+CD11b+ cells isolated
from mouse liver tissue (Kinoshita et al., 2010; Movita et al.,
2012). There is another possibility that these subpopulations
are actually distinct differentiation phases rather than distinct
Kupffer cells subpopulations, or maybe they only represent
the different stages of infiltrating inflammatory monocytes
instead of resident tissue macrophages.
In this study, we identified a new subset of CD69+ Kupf-
fer cells in the mouse models with L. monocytogenes infec-
tion. These CD69+ Kupffer cells express extremely higher
level of membrane-bound TGF-β1 (mTGF-β1), and produced
similar levels of IFN-γ, IL-12 with CD69− Kupffer cells. In-
terestingly, these CD69+ Kupffer cells could inhibit CD4 T
cell immune response in vitro and in vivo through mTGF-
β1, but not via traditional manner like production of soluble
molecules. The inflammation-induced CD69+ Kupffer cells
may play an important role in the termination of the immune
response at the late stage of immune response against infec-
tion when pathogens have been eliminated, thus protecting
host from immunopathological damage by controlling im-
mune response. Our data provide new insight to the immuno-
biology and function of hepatic Kupffer cells.
RESULTS
Expansion of CD69+ Kupffer cells in response to intracel-
lular bacterial infection
For analyzing diverse hepatic Kupffer cell subsets, we
infected mice with L. monocytogenes and analyzed the
phenotype variations of hepatic Kupffer cells. Among the
various phenotype markers, the expression of CD69 on
hepatic Kupffer cells attracted our attention. CD69+ Kupffer
cells contained 15%−17% of liver isolation of mononuclear
cell (MNC) (Figure 1A) and 70%−80% of liver Kupffer
cells (data not shown), and most of the CD69+ Kupffer cells
(~84.7%) expressed CD11b (Figure 2), on day 4 and 6 after
injection of bacteria. Through the kinetics of CD69 expres-
sion on liver Kupffer cells after L. monocytogenes infection,
we found that the CD69 expression dramatically increased
on day 4 and 6, and then declined rapidly to ~4.1% on day 8
and to the normal level after infection (Figure 1B).
To confirm the validity of this mouse model, we detected
the bacterial burdens in the liver at different times after L.
monocytogenes infection. The bacterial titers peaked on day 2
of infection, then declined, and completely eliminated on day
10 (Figure 1C).  These  data  indicate  that L. monocytogenes
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Figure 1   Expression of CD69 on hepatic Kupffer cells during L. monocytogenes infection. A, Flow cytometry analysis of the CD69 expression on hepatic
F4/80+ Kupffer cells from L.monocytogenes-infected mice after different days. B, Statistical analysis of CD69+ cells in total hepatic MNC (%). C, Titers of
L.monocytogenes in the liver of the mice different days after L.monocytogenes infection. The dot plots represent one of five independent experiments with
similar results. Means±SE (n=5; eight mice per group).
infection-induced and/or -expanded CD69+ Kupffer cells ex-
isted in themid- and late stages of infection and occupied high
proportion in total hepatic Kupffer cells.
Liver Kupffer cells have been proposed to be heteroge-
neous macrophage lineage cells. F4/80 is a representative
surface marker of mouse mononuclear phagocytes. CD11b,
a C3b receptor, is expressed on the surface of mono-
cytes/macrophages, granulocytes, and NK cells. CD68
(macrosialin) is also used as a marker of macrophages,
including Kupffer cells. This antigen is predominantly
localized in the cytosol of macrophages but is expressed
on the cell surface upon activation. The present studies
suggested that mouse F4/80+ Kupffer cells may be subclas-
sified into two major subsets according to their phenotype
and function: the CD68+ subset with phagocytic capacities,
and the CD11b+ subset, with a potent capacity to produce
cytokines and chemokines. In addition, CD11b+ Kupffer
cells/macrophages may be migrated from the bone marrow
or spleen, especially in inflammatory conditions of the liver.
In our experiments, large amounts of CD69+ Kupffer cells
express high levels of CD11b (~84.7%) and low levels of
CD68 (~5.2%), meanwhile, it was found that the proportion
of hepatic CD69+ Kupffer cell subset do not change sig-
nificantly with clodronate liposome administration (Figure
2). Together with above data, the results demonstrate that
CD69+CD11b+ Kupffer cells, derived from circulating mono-
cytes, are inducible and significantly expanded in response
to infections.
Distinct phenotype and cytokine profile of CD69+Kupffer
cells
The maximal proportion of CD69+ Kupffer cells in hepatic
Figure 2   Hepatic CD69+ Kupffer cells during L.monocytogenes infection
belong to CD11b+ Kupffer cells/macrophages. Mice were i.p. injected with
200 μL of clodronate liposomes 24 h before L.monocytogenes infection.
Flow cytometry analysis of the CD68 and CD11b expression on hepatic
F4/80+ Kupffer cells cells from L.monocytogenes-infected mice zero day
and six days with or without administration of clodronate liposomes. The
dot plots represent one of five independent experiments with similar results.
Kupffer cells is induced on day 6 after L. monocytogenes in-
fection, so we analyzed hepatic Kupffer cells on day 6 af-
ter infection in the following experiments for phenotypic and
functional investigation. First, we analyzed the phenotype of
CD69+ Kupffer cells, comparing with CD69− Kupffer cells.
We found that most of CD69+ Kupffer cells (~93.5%) ex-
pressed relatively high levels of mTGF-β1, while only few
CD69− Kupffer cells (~0.7%) expressed mTGF-β1 (Figure
3A).
Kupffer cells always display their roles through secretion
of different cytokines, so we analyzed the cytokine profile of
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Figure 3   Distinct phenotype and cytokine profile of CD69+Kupffer cells. A, Flow cytometry analysis of hepatic CD69+ or CD69−Kupffer cells (day 6) stained
with anti-TGF-β1 PE, anti-IFN-γ PE and anti-IL-12 p40 PE respectively. The dot plots represent one of five independent experiments with similar results. B,
Hepatic CD69+ or CD69− Kupffer cells (day 6) were purified and stimulated with LPS for 24 h in RPMI-1640. Supernatants were collected for IFN-γ, IL-12
and TGF-β1 detection by ELISA. Means±SE (n=4; five mice per group). *, P>0.05.
CD69+ Kupffer cells. The supernatants from purified hepatic
CD69+ or CD69− Kupffer cells stimulated with LPS for 24 h
were collected, and IFN-γ, IL-12 or TGF-β1 concentrations
were determined by ELISA. As expected, CD69+ and CD69−
Kupffer cells produced relatively high levels of IFN-γ and
IL-12 after stimulation, and secreted low level of TGF-β1,
while there was no significant difference between these two
subsets (Figure 3). These data show that CD69+Kupffer cells
might exhibit their functions through the other untraditional
manner besides being potent cytokine-producers.
CD69+ Kupffer cells inhibit CD4 T cell proliferation in
vitro but not interfere with activation of proliferating CD4
T cells
As studied above, CD69+ Kupffer cells occupy the maximal
proportion in hepatic Kupffer cells on day 4−6 after L.
monocytogenes infection. This is the mid- and late stage
of infection when the L. monocytogenes are almost elim-
inated. Usually, the immune response at the late stage of
this acute infection model should be negatively regulated,
so as to avoid immunopathological damage to selftissue.
Meanwhile, these cells express high level of the potent
immunosuppressive molecule mTGF-β1, so we hypothesize
that CD69+ Kupffer cells may play immunosuppressive
functions through mTGF-β1. To testify this hypothesis,
we detected whether these cells could inhibit CD4 T cell
response in vitro. Splenic CD4 T cells, isolated from normal
mice, proliferated after cultured for five days in the presence
of anti-CD3 and anti-CD28 mAbs. Obviously, when co-
cultured with hepatic CD69+ Kupffer cells purified from L.
monocytogenes-infected mice on day 6, the proliferation of
CD4 T cells was suppressed, while the proliferation was not
affected when cocultured with CD69− Kupffer cells (Figure
4A). So, we proved that hepatic CD69+ Kupffer cells, but not
CD69− Kupffer cells, can inhibit Ag-nonspecific CD4 T cell
proliferation.
We also detected whether CD69+ Kupffer cells could sup-
press Ag-specific CD4T cell proliferation. Splenic OVA-spe-
cific CD4 T cells massively proliferated after cocultured with
mDCs for five days in the presence of OVA323−339 (Figure 4B).
Accordingly, when cocultured with hepatic purified CD69+
Kupffer cells, the proliferation of CD4 T cells was signif-
icantly suppressed, while the proliferation was not affected
when cocultured with CD69− Kupffer cells (Figure 4B), sug-
gesting that CD69+ Kupffer cells also can suppress Ag-spe-
cific CD4 T cell proliferation.
Then, we analyzed whether CD69+ Kupffer cells could af-
fect activation of  CD4 T  cells  by  intracellular staining and
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Figure 4   CD69+ Kupffer cells inhibit CD4 T cell proliferation in vitro. A, The suppressive effect of CD69+ Kupffer cells on Ag-nonspecific CD4 T cell
proliferation. Purified CD4 T cells from normal C57BL/6 mice were cultured for five days in the presence of anti-CD3 mAb and anti-CD28 mAb, together with
or without purified CD69+ or CD69−Kupffer cells. The total number of live CD4 T cells in each well was measured by flow cytometry. B, The suppressive effect
of CD69+ Kupffer cells on OVA-specific CD4 T cell proliferation. Purified CD4 T cells from normal (DO11.10×C57BL/6) F1 hybrid mice were cocultured with
mature dendritic cells (mDCs) for five days in the presence of OVA323−339, together with or without purified CD69+ or CD69− Kupffer cells. The total number of
live KJ1-26+CD4+ T cells in each well was measured by flow cytometry. C−E, CD69+Kupffer cells don’t affect the activation of CD4 T cells. After proliferation
for five days described above in B, the intracellular IFN-γ expression of CD4 T cells was detected by flow cytometry. The proportion of IFN-γ+ in total CD4 T
cells (C) and the representable dot plots (D) are shown. Supernatants were collected for IFN-γ detection by enzyme linked immunosorbent assay (ELISA) (E).
Means±SE (n=4; five mice per group). *, P>0.05; ***, P<0.01.
ELISA assay of IFN-γ expression. As shown in Figure 4C
and D, adding hepatic purified CD69+ Kupffer cells into the
coculture system didn’t affect the proportion of IFN-γ+CD4T
cells induced by OVA323−339-pulsed mDCs, which was further
supported by ELISA (Figure 4E). Therefore, the data show
that hepatic CD69+ Kupffer cells could suppress Ag-nonspe-
cific and OVA-specific CD4 T cell proliferation, but did not
interfere with activation of proliferating CD4 T cells.
CD69+ Kupffer cells inhibit CD4 T cell proliferation in
vivo
To confirm the inhibition function of hepatic CD69+ Kupf-
fer cells on CD4 T cell proliferation in vivo, we adoptively
transferred OVA323−339-loaded mDCs, together with or with-
out hepatic purified CD69+ Kupffer cells or CD69− Kupffer
cells, into the mice pre-injected with OVA-specific CD4 T
cells. Consistent with the previous results in vitro, the trans-
ferred hepatic CD69+ Kupffer cells distinctly reduced the fre-
quency of KJ1-26+CD4+ T cells in the liver, while hepatic
CD69− Kupffer cells could not (Figure 5A and B), suggest-
ing that CD69+ Kupffer cells inhibit CD4 T cell proliferation
in vivo.
CD69+ Kupffer cells suppress T cell proliferation via
membrane-bound TGF-β1
Finally, we analyzed the underlying mechanisms for the
inhibition function of hepatic CD69+ Kupffer cells on CD4
T cells. To determine whether soluble factor produced by
CD69+ Kupffer cells or cell-cell contact is responsible for
the suppressive effect, we incubated CD69+ Kupffer cells
and OVA peptide/mDCs/T cells in the transwell system
(0.4 μm), or incubated the fixed CD69+ Kupffer cells with
OVA peptide/mDCs/T cells. As shown in Figure 6, CD69+
Kupffer cells lost their suppressive ability in the transwell
system, while the fixed CD69+ Kupffer cells still played the
suppressive effect, demonstrating that the inhibition of T cell
proliferation depends on cell-cell contact, but not via soluble
molecules.
Considering that CD69+ Kupffer cells expressed high level
of mTGF-β1, we detected whether mTGF-β1 mediated the
suppressive ability of CD69+ Kupffer cells. Using neutral-
izing anti-TGF-β1 mAb, we found that neutralization of
TGF-β1 in the coculture system restored the OVA-specific
CD4 T cell proliferation in the presence of hepatic CD69+
Kupffer  cells  (Figure 6).  Consequently,  the  above  data
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Figure 5   CD69+ Kupffer cells inhibit CD4 T cell proliferation in vivo. A and B, OVA323−339-pulsed mDCs and purified CD4 T cells from normal
(DO11.10×C57BL/6) F1 hybrid mice were transferred, together with or without purified CD69+ or CD69− Kupffer cells, into recipient mice. After five days,
the hepatic MNCs were stained with CD4-FITC, KJ1-26-PE and 7AAD for analysis by flow cytometry. The representable dot plots (A) and the proportions of
KJ1-26+ in total CD4 T cells from liver (B) are shown. Means±SE (n=4; eight mice per group). ***, P<0.01.
Figure 6   CD69+ Kupffer cells inhibit CD4 and CD8 T cell proliferation
through mTGF-β1. Purified CD4 T cells from normal (DO11.10×C57BL/6)
F1 hybrid mice were cocultured with mDCs for five days in the presence of
OVA323−339, together with or without purified CD69+ Kupffer cells. The to-
tal number of live KJ1-26+CD4+ T cells in each well was measured by flow
cytometry. In some experiments, 0.4-μm Transwells were used to separate
mDCs/T cells from CD69+ Kupffer cells in the coculture system (transwell),
or neutralizing mAb against mouse TGF-β1 was added to the coculture sys-
tem. Fixation, coculture system of mDCs/T cells with CD69+ Kupffer cells
which were fixed before being added into the coculture system; and isotype,
isotype control for anti-TGF-β1mAb. Means±SE (n=4; fivemice per group).
***, P<0.01.
demonstrate that hepatic CD69+ Kupffer cells inhibit T cell
proliferation via their expression of mTGF-β1.
DISCUSSION
It is well known that Kupffer cells have been demonstrated
to play a critical role in innate immunity against bacteria,
parasites, yeasts, and viruses, because they can produce large
kinds of cytokines rapidly after infection with microbial
pathogens. Kupffer cells not only act as innate effector cells
but also as regulator of innate and adaptive immunity during
the microbial infection by secreting immunosuppressive
cytokines. Kupffer cells are constantly exposed to pathogen
derived products from the gut. To prevent excessive inflam-
mation and pathology of the liver, continuous activation of
Kupffer cells is avoided as these cells become refractory
to subsequent endotoxin challenge, a phenomenon known
as endotoxin-tolerance (Biswas and Lopez-Collazo, 2009;
Thomson and Knolle, 2010). This contributes to the well-de-
scribed tolerogenic microenvironment in the liver. Besides
modulation of TLR-signaling pathways, also expression of
anti-inflammatory mediators, such as IL-10 and TGF-β, and
other soluble and membrane-bound inhibitory molecules are
underlying the intrahepatic tolerance (Thomson and Knolle,
2010; Roth et al., 1998; You et al., 2008; Mengshol et al.,
2010).
In the present study, we analyzed the variation of pheno-
types and functions of Kupffer cells in the liver of the mice
infected with L. monocytogenes, a model organism that is
widely used to dissect the mechanisms of innate and adaptive
immune response to infection (Williams et al., 2012). Among
the various phenotype markers, we found the expression of
CD69 may be used to study the subpopulations and func-
tion of Kupffer cell. After infection of L. monocytogenes, the
CD69 expression of hepatic Kupffer cells dramatically upreg-
ulated, with peak expression on day 4−6 of infection, and then
suddenly declined to the normal level along with diminish-
ment of bacteria. To further analyze the relationship between
CD69 expression and functions of Kupffer cells, we classi-
fied two subsets of Kupffer cells, including CD69+ Kupffer
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cells and CD69− Kupffer cells. We found that CD69+ Kupf-
fer cells expressed relatively higher levels of mTGF-β1, and
produced large amounts of IFN-γ and IL-12, and low level
of TGF-β1 simultaneously. The most obvious difference be-
tween CD69+ and CD69− Kupffer cells is the expression of
mTGF-β1, a potent immunosuppressive molecule. Together
with the functional data that hepatic CD69+ Kupffer cells,
but not CD69− Kupffer cells, suppressed CD4 T cell prolif-
eration in vitro and in vivo through mTGF-β1, we identified
CD69+mTGF-β1+ Kupffer cells subset as regulatory Kupffer
cells, induced by inflammation.
Previous studies have reported that virus components af-
fect the production of immunoregulatory cytokines, and con-
sequently promote the tolerogenic microenvironment of the
liver. On this point, it has been demonstrated that hepatitis
B virus (HBV) particles preferably induced TGF-β produc-
tion by rat Kupffer cells, but not pro-inflammatory cytokines.
It is an important role of TGF-β played in maintaining toler-
ance towards self-antigens that selectively support the differ-
entiation of FoxP3+ regulatory T cells (Oertelt et al., 2006;
Gandhi et al., 2007). Increased intrahepatic IL-10 levels may
inhibit pro-inflammatory cytokine production by intrahepatic
cells, blockage of Kupffer cells-NK cell interaction (Lassen
et al., 2010) and antigen presentation to T cells and their ac-
tivation (Lassen et al., 2010). Kupffer cells express mem-
brane-bound inhibitory ligands that could facilitate a tolero-
genic milieu in the liver. Such as, under steady state condi-
tions, Kupffer cells are reported to express PD-L1, which is
a ligand for PD-1 and known to suppress T cell function by
inhibiting proliferation and cell division (Iwai et al., 2003).
Now, our identification of regulatory CD69+ Kupffer cells
provides new evidence for the presence of particular Kupf-
fer cells subset responsible for the regulatory properties of
Kupffer cells previously reported. Unexpectedly, we proved
here that CD69+ Kupffer cells regulatory Kupffer cells inhib-
ited T cell response through mTGF-β1, but not soluble fac-
tors, suggesting that Kupffer cells also could take advantage
of cell surface TGF-β1 to show their various functions other
than various cytokines they produced. Therefore, our data not
only enrich the family of regulatory Kupffer cells, but also
help us have better understanding of the immune regulation
function of Kupffer cells.
In our work, the CD69 expression on hepatic Kupffer cells
was remarkably up-regulated during process of infection. In
the late stage of infection, 80%−90% hepatic Kupffer cells
were CD69 positive, and CD69+ Kupffer cells not only were
activated cells induced by inflammation but also could in-
hibit CD4 T cell proliferation through mTGF-β1 in a cell
contact-dependent manner. CD69 belongs to the C-lectin
type superfamily, which appears to be the earliest inducible
cell surface glycoprotein induced during lymphoid activation,
is involved in lymphocyte proliferation and functions as a
signal-transmitting receptor in lymphocytes, including nat-
ural killer (NK) cells, and platelets. Previous studies have
also shown that CD69, an activating marker of T cells, is
persistently expressed in chronic inflammation. Engagement
of CD69 can activate NK and T cells, resulting in the up-
regulated cytotoxic activity and pro-inflammatory cytokines
secretion (Sancho et al., 2005).Owing to the absence of a
known ligand, the biological function and underlying mech-
anisms of CD69 have not been extensively studied. In re-
cent years, CD69 has been reported as the negative regulating
factor for the T cell response because CD69-deficient mice
develop more severe T cell-mediated autoimmune diseases,
meanwhile, CD69 deficiency could promote the antitumor re-
sponse (Radulovic and Niess, 2015; Wieland and Shipkova,
2016). Furthermore, CD69 engagement can not only induce
apoptosis in monocytes and eosinophils, and also suppress
IL-1 receptor- or CD3-mediated T cell proliferation (Ramírez
et al., 1996; Walsh et al., 1996; Cosulich et al., 1987). The
subset of CD4+CD69+ T cells, detected in peripheral lym-
phoid tissues of a murine lupus model, is demonstrated be-
ing anergic, with impaired ability to produce pro-inflamma-
tory cytokines. CXCR4/CXCL12 play critical role in the pro-
motion of tumor growth and metastasis. It is shown that the
proportion of CD4+CD69+CXCR4+ T cells increases in the
tumor, by analyzing the CXCR4 expression on the tumor-in-
filtrating immune cells isolated from lung adenocarcinoma.
30% of these CD4+CD69+CXCR4+ T cells express high lev-
els of CD25 and Foxp3. However, there was no functional
study of these T cells as inhibitor of T cell response and the
biological significance and underlying mechanisms of CD69
for the function of these T cells was not studied intensively.
Consistent with the above studies, CD69 expressed on Kupf-
fer cells during L. monocytogenes infection not only plays
as an activation marker, but also triggers inhibitory signal in
CD4 T cell proliferation. And the underlying mechanisms for
how pathogen infection induces generation and expansion of
CD69+ Kupffer cells and how mTGF-β1 is induced on the
surface of CD69+ Kupffer cells remain to be elucidated in the
future.
Liver is not only a lymphoid organ, but also an immune
tolerogenic organ. The liver tolerance may mediate local and
systemic tolerance to self and foreign antigens. There are lots
of specialized hepatic infiltrated cells attributed to immune
tolerance, including DCs, liver sinusoidal endothelial cells,
hepatic stellate cells as well as CD4+CD25+Foxp3+ Tregs, all
of these cells express anti-inflammatory fectors and/or in-
hibitory cell surface ligands such as IL-10, Il-4, TGF-β1,
PD-L1 and CTLA-4. However, the precise mechanisms for
liver tolerance have not been totally elucidated yet. Kupffer
cells are most abundant in the liver, so Kupffer cells are prob-
ably involved in the tolerance effect of liver. In this study, we
found that ~90% hepatic Kupffer cells express CD69 at the
mid- and late stage of infection, so we consider that regula-
tory CD69+ Kupffer cells, the activated cell subset induced
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by inflammation, contribute to the tolerogenic properties of
liver through expressing mTGF-β1 simultaneously. Further-
more, our results have determined that CD69+ Kupffer cells
suppress CD4 T cell proliferation without influence activa-
tion of CD4 T cells, suggesting that CD69+ Kupffer cells can
control the immune response to the appropriate level by limit-
ing the number of CD4 T cells but still maintain the activation
of effector CD4 T cell functions, favoring the elimination of
invading bacteria.
TGF-β1 has long been considered as one of the most im-
portant immunosuppressive cytokines (Li et al., 2006). For
example, TGF-β1 not only plays important roles in inhibitory
mechanisms of Tregs, but also is essential to the inducement
of iTreg cells and Treg maintenance in general (Vignali et
al., 2008; Chen et al., 2003). In addition to soluble TGF-β1,
mTGF-β1 also can mediate suppression function expressed
on Tregs in a cell-cell contact-dependent manner (Nakamura
et al., 2001, Green et al., 2003). It is found that human tu-
mor-derived exosomes enhance the inhibitory functions of
Tregs by mTGF-β1 (Clayton et al., 2007). What’s more, in
anti-tumor immunity, tumor apoptotic bodies inhibit CTL re-
sponse by inducing CD8 T cell anergy and generation of reg-
ulatory T cell 1 (Tr1) response through mTGF-β1 (Xie et al.,
2009). Our group previously showed that cancer-expanded
myeloid-derived suppressor cells (MDSCs) induced anergy
of NK cells through mTGF-β1 (Li et al., 2009), tumor-in-
duced CD4+CD69+CD25−Foxp3− Tregs suppress CD4 T cell
proliferation through mTGF-β1 (Han et al., 2009; Han et al.,
2014), and apoptotic cells attenuated fulminant hepatitis by
priming Kupffer cells to produce IL-10 through mTGF-β1
(Zhang et al., 2011), pathogen induced hepatic CD11b+ regu-
latory NKT cells inhibit CD4 and CD8 T cell response in vitro
and in vivo through mTGF-β1 (Han et al., 2015). Together
with this study in which inflammation-induced CD69+ Kupf-
fer cells which can feedback inhibit CD4 T cell response via
mTGF-β1, we can conclude that mTGF-β1 may be the im-
portant, shared common mechanism for mediating negative




C57BL/6 mice were purchased from Joint Ventures Sipper
BK Experimental Animal Co. (Shanghai) and used at the age
of 6−8 weeks. The OVA-specific TCR transgenic DO11.10
mice were purchased from The Jackson Laboratory and bred
in specific pathogen-free conditions. All experimental ma-
nipulations were undertaken in accordance with the National
Institutes of Health Guide for the Care and Use of Labora-
tory Animals, with the approval of the Scientific Investigation
Board of the Second Military Medical University, Shanghai,
China.
Reagents
The Abs for flow cytometry, including Abs against F4/80
(BM8), CD68 (FA-11), CD11b (M1/70), CD69 (H1.2F3),
TGF-β1 (2Ar2), TCR DO11.10 (KJ1-26), and IL-12/IL-23
p40 (C15.6), IFN-γ (XMG1.2), and activating anti-CD3
(145-2C11) and anti-CD28 (37.51) mAbs were from BD
PharMingen (USA). Anti-TGF-β1 Ab (1D11) and its isotype
control mouse IgG1 mAb (11711), and all ELISA kits were
from R&D Systems (USA). Lipopolysaccharide (LPS),
7-AAD, clodronate liposomes and PBS liposomes, and
OVA323−339 were from Sigma-Aldrich (USA).
Bacterial infections and quantification
L. monocytogenes strain (rLM6) was kindly provided by Dr.
Hao Shen (University of Pennsylvania School of Medicine,
Philadelphia, PA). Bacteria were grown overnight in brain-
heart infusion broth. Aliquots were thawed and bacterial
titers were determined by plating serial dilutions on brain-
heart infusion broth agar plates. For infection, aliquots were
thawed and appropriately diluted in PBS, and 1.5×104 bacte-
ria were injected in a volume of 200 μL PBS into the lateral
tail veins of mice. Bacteria in the liver were measured at the
different time after infection by homogenization and lysis of
tissues in 5mL of 0.05% (v/v) TritonX-100, followed by plat-
ing onto brain-heart infusion plates. Total colonies per liver
were counted after incubation overnight at 37°C (Han et al.,
2015).
Depletion of liver Kupffer cells by clodronate liposomes
For depletion of liver Kupffer cells, mice were i.p. injected
with 200 μL of clodronate liposomes (Sigma Chemical Co.,
USA) 24 h before L. monocytogenes infection (Kinoshita et
al., 2010).
MNCs from liver
Liver specimens were minced thoroughly with scissors and
digestedwith collagenase IV for 0.5 h, and then the single-cell
suspension was filtered through a 40-μm cell strainer (BD
Falcon, USA).MNCswere purified by centrifugation through
a Percoll gradient. Cells were collected, washed, and resus-
pended in 33% Percoll (Sigma-Aldrich). Then the cell sus-
pensionwas gently overlaid onto 67%Percoll and centrifuged
for 20min at 750×g. MNCswere collected from the interface,
washed twice with PBS, and re-suspended in 1640.
Flow cytometry
Before staining with fluorescent Abs, cells were incubated for
15 min with Ab against CD16/32 for blockade of Fc recep-
tors. Fluorsecent Abs and their respective isotype controls
(1 μg 106 cells−1 100 μL−1) were then added, and cells were in-
cubated for 30 min at 4°C. The cells were washed with PBS
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containing 0.1% NaN3 and 0.5% BSA, and resuspended in
200 μL PBS. Cell phenotype was analyzed by flow cytome-
try with a FACS LSRFortessa (BD Biosciences, USA), and
data were analyzed with FACSDiva software.
For intracellular staining of IFN-γ or IL-12 p40, cells were
stimulated with 100 ng mL−1 LPS for 24 h, and brefeldin A
(10 μg mL−1) was included for the last 6 h of incubation.
Cells were collected and then fixed and permeabilized with
the Cytofix/Cytoperm kit according to the manufacturer’s in-
structions (eBioscience, USA). The cells were washed with
permeabilization buffer and labeled with PE anti-IFN-γ mAb,
PE anti- IL-12 p40 mAb or its isotype control. Flow cytom-
etry was done with a FASC LSRFortessa.
Isolation and purification of hepatic CD69+ Kupffer cells
and CD69− Kupffer cells
Hepatic MNCs were prepared from L. monocytogenes in-
fected mice (day 6). Cells were stained with anti-CD69 PE
and anti-F4/80 APC, and then CD69+F4/80+ cells (CD69+
Kupffer cells) and CD69−F4/80+ cells (CD69− Kupffer cells)
were sorted respectively by MoFlo high-speed cell sorter
(Dako, Denmark). The purity of each population was con-
firmed by FACS to be >97%.
Preparation of mDCs from mouse bone marrow
DCs were prepared from mouse bone marrow progenitors by
culturing in 10 ng mL−1 recombinant mouse GM-CSF and
1 ng mL−1 recombinant mouse IL-4 (PeproTec, USA) as de-
scribed previously. Briefly, nonadherent cells were gently re-
moved on day 3 of culture, and the remaining adherent cells
were cultured for another 4−5 days in the presence of 10 ng
mL−1 LPS (Sigma-Aldrich). Then cells were positively iso-
lated from floating cells with CD11c magnetic microbeads
(Miltenyi Biotec, USA) and used formDCs (Han et al., 2015).
Detection of cytokines by ELISA
For detection of IFN-γ, IL-12p40 or TGF-β1 secretion, cell
supernatants were collected, and the cytokine concentrations
were determined by ELISA kits (R&D).
Assay for Ag-nonspecific CD4 T cell proliferation in vitro
Splenic CD4 T cells from normal C57BL/6 mice were
purified by magnetic-activated cell sorting (MACS) for
use as responders, and then cultured for five days in the
presence of anti-CD3 mAb (10 μg mL−1) and anti-CD28
mAb (2 μg mL−1), together with or without purified CD69+
or CD69− Kupffer cells at the ratio of 10:1 (T cells/Kupffer
cells) (1×105 T cells in 200 μL well−1). Then cells were
harvested, stained with anti-CD4-FITC and 7-AAD, resus-
pended in 200 μL−1 PBS, and cellular data were acquired for
70 s with FACS LSRFortessa (1×105 PE-labeled beads were
added to each well as an internal control before Ab labeling).
The number of CD4+7AAD− cells and control bead events
acquired were analyzed, and the total cells in each well were
calculated according to the formula: total no.=(no. live CD4
or CD8/no. beads)×105.
Assay for OVA-specific CD4 T cell proliferation in vitro
Splenic CD4 T cells from normal (DO11.10×C57BL/6) F1
hybrid mice were purified by MACS, and then cocultured
with mDCs for five days at the ratio of 10:1 (T cells/mDCs)
(1×105 T cells in 200 μl well−1) in the presence of OVA323−339,
together with or without purified CD69+ or CD69− Kupffer
cells. The ratios ofmDCs andKupffer cells were 1:1. In some
experiments, 0.4-μm Transwells were used to separate Kupf-
fer cells from T cells/mDCs in the coculture system, or Kupf-
fer cells were fixed with 1% glutaraldehyde before adding to
the coculture system. For the blocking assay, 10 μgmL−1 anti-
TGF-β1 mAb was added to the coculture system. After five
days, the cells were collected and stained with anti-CD4-
FITC, KJ1-26-PE and 7-AAD, and cellular data were ac-
quired for 70 s with FACS LSRFortessa. The total numbers
of CD4+KJ1-26+7-AAD− cells were calculated as described
above (Han et al., 2015).
Assay for OVA-specific T cell proliferation in vivo after
adoptive transfer of CD69+ Kupffer cells
OVA-specific TCR-transgenic splenic CD4 T cells (5×106)
from normal (DO11.10×C57BL/6) F1 hybrid mice were in-
jected i.p. into (BALB/c×C57BL/6) F1 hybrid mice. After
24 h, 5×106 OVA323−339-pulsed mDCs, together with or with-
out the same number of purified CD69+ or CD69− Kupffer
cells, were transferred i.p. into the mice. After five days, he-
patic MNCs were prepared, and the cells were stained with
anti-CD4-FITC, KJ1-26-PE and 7-AAD, and then analyzed
by flow cytometry. The ratios of KJ1-26+ cells in total CD4
T cells were calculated (Han et al., 2015).
Statistical analysis
Data were analyzed for statistical significance using Student’s
t test. Statistical significance was determined as P<0.05.
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